Metformin Associated With Reduced Left Ventricular Hypertrophy in Patients With Coronary Artery Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
A Randomized Controlled Trial of Metformin on Left Ventricular Hypertrophy in Patients With Coronary Artery Disease Without Diabetes: The MET-REMODEL Trial
Eur Heart J 2019 Apr 17;[EPub Ahead of Print], M Mohan, S Al-Talabany, A McKinnie, IR Mordi, JSS Singh, SJ Gandy, F Baig, MS Hussain, U Bhalraam, F Khan, AM Choy, S Matthew, JG Houston, AD Struthers, J George, CC LangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.